Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
about
Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model.Pharmacodynamic effects of subinhibitory concentrations of imipenem on Pseudomonas aeruginosa in an in vitro dynamic model.Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration.
P2860
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
@en
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
@nl
type
label
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
@en
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
@nl
prefLabel
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
@en
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
@nl
P356
P1433
P1476
Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
@en
P2093
P356
10.1159/000238915
P478
37 Suppl 2
P577
1991-01-01T00:00:00Z